The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.
Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
Open accessAbstract
In the field of nonviral gene therapy, in vitro transcribed (IVT) mRNA has emerged as a promising tool for the delivery of genetic information. Over the past few years it has become widely known that the introduction of IVT mRNA into mammalian cells elicits an innate immune response that has favored mRNA use toward immunotherapeutic vaccination strategies. However, for non-immunotherapy-related applications this intrinsic immune-stimulatory activity directly interferes with the aimed therapeutic outcome, because it can seriously compromise the expression of the desired protein. This review presents an overview of the immune-related obstacles that limit mRNA advance for non-immunotherapy-related applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however, antigen non-specific stimulation of type I interferon pathways has been demonstrated with other formulations of mRNA in animal models78,79.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [79]
In the citing paper
“Uridine-containing mRNA stimulates the innate immune response and has an established adjuvant function when used as a vaccine.34,35”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [34]
In the citing paper
“These limitations are based on the intrinsic immunogenicity of unmodified mRNA due to intracellular detection131,132 and type I interferon (IFN) production,34 which in turn is responsible for the inhibition of translation, the reduction of CD8+ T cell activation, and the inhibition of T helper cell generation.”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,486
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 4,022
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Innate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
Krieg, P. A., & Melton, D. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7057 · Cited by 1,533
Genetic immunization is a simple method for eliciting an immune response
Tang, D.-C. C., DeVit, M. J., & Johnston, S. A. (1992) · Nature · doi:10.1038/356152a0 · Cited by 1,504
Toll-like receptors and innate immunity
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.062 · Cited by 1,221
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Allen, I. C., Scull, M. A., Moore, C. B., Holl, E. K., McElvania-TeKippe, E., Taxman, D. J., Guthrie, E. H., Pickles, R. J., & Ting, J. P.-Y. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.005 · Cited by 1,113
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Circularization of mRNA by Eukaryotic Translation Initiation Factors
Wells, S. E., Hillner, P. E., Vale, R. D., & Sachs, A. B. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80122-7 · Cited by 968
Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898
The IKK Complex, a Central Regulator of NF- B ActivationPreprint
Israël, A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000158 · Cited by 853
Quintás-Cardama, A., Vaddi, K., Liu, P., Manshouri, T., Li, J., Scherle, P. A., Caulder, E., Wen, X., Li, Y., Waeltz, P., et al. (2010) · Blood · doi:10.1182/blood-2009-04-214957 · Cited by 843
Schlee, M., Roth, A. H. F. J., Hornung, V., Hagmann, C. A., Wimmenauer, V., Barchet, W., Coch, C., Janke, M., Mihailovic, A., Wardle, G. S., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.008 · Cited by 814
Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1979 · Cited by 811
Ballas, Z. K., Rasmussen, W. L., & KRIEG, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 758
Activation of innate immune antiviral responses by Nod2
Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V. C., Tominaga, K., Dube, P. H., Xiang, Y., & Bose, S. (2009) · Nature Immunology · doi:10.1038/ni.1782 · Cited by 754
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
LGP2 is a positive regulator of RIG-I– and MDA5-mediated antiviral responses
Satoh, T., Kato, H., Kumagai, Y., Yoneyama, M., Sato, S., Matsushita, K., Tsujimura, T., Fujita, T., Akira, S., & Takeuchi, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912986107 · Cited by 722
Kanneganti, T., Body–Malapel, M., Amer, A. O., Park, J., Whitfield, J. R., Franchi, L., Taraporewala, Z. F., Miller, D. J., Patton, J. T., Inohara, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607594200 · Cited by 706
Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R. M., Romani, N., & Schuler, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260323 · Cited by 700
Pichlmair, A., & Sousa, C. R. E. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.012 · Cited by 690
Silverman, R. H. (2007) · Journal of Virology · doi:10.1128/jvi.01471-07 · Cited by 689
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R. M., Sparwasser, T. D., Heeg, K. M., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 670
Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646
Rothenfußer, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S., & Fitzgerald, K. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5260 · Cited by 645
The dsRNA protein kinase PKR: Virus and cell control
García, M. A., Meurs, E. F., & Esteban, M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.001 · Cited by 644
Gene delivery by lipoplexes and polyplexes
de Ilarduya, C. T., Sun, Y., & Düzgüneş, N. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.019 · Cited by 626
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines
Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000702 · Cited by 606
Kumar, A., Haque, J., Lacoste, J., Hiscott, J. B., & Williams, B. R. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6288 · Cited by 568
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates
Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., et al. (2014) · Nature · doi:10.1038/nature13590 · Cited by 557
Essential Role for the dsRNA-Dependent Protein Kinase PKR in Innate Immunity to Viral Infection
Balachandran, S., Roberts, P. C., Brown, L. E., Truong, H., Pattnaik, A. K., Archer, D. R., & Barber, G. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00014-5 · Cited by 527
Coller, J., & Parker, R. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074032 · Cited by 500
ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
Hartner, J. C., Walkley, C. R., Lü, J., & Orkin, S. H. (2008) · Nature Immunology · doi:10.1038/ni.1680 · Cited by 493
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
Martinon, F., Krishnan, S., Lenzen, G., Magné, R., Gomard, E., Guillet, J., Lévy, J., & Meulien, P. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230749 · Cited by 473
Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection
Pichlmair, A., Schulz, O., Tan, C.-P., Rehwinkel, J., Kato, H., Takeuchi, O., Akira, S., Way, M., Schiavo, G., & Sousa, C. R. E. (2009) · Journal of Virology · doi:10.1128/jvi.00770-09 · Cited by 469
Karikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446
5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I
Schmidt, A., Schwerd, T., Hamm, W., Hellmuth, J. C., Cui, S., Wenzel, M., Hoffmann, F. S., Michallet, M.-C., Besch, R., Hopfner, K.-P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900971106 · Cited by 398
Halpern, M. D., Kurlander, R. J., & Pisetsky, D. S. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0009 · Cited by 395
Clark, K., Plater, L., Peggie, M. W., & Cohen, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000414 · Cited by 389
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
Mantovani, A., Locati, M., Vecchi, A., Sozzani, S., & Allavena, P. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01941-x · Cited by 383
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
Smith, G. L., Benfield, C. T. O., de Motes, C. M., Mazzon, M., Ember, S. W., Ferguson, B. J., & Sumner, R. P. (2013) · Journal of General Virology · doi:10.1099/vir.0.055921-0 · Cited by 364
Martin, S., Paoletti, E., & Moss, B. A. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40646-7 · Cited by 355
Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming
Lee, J., Sayed, N., Hunter, A. L., Au, K. F., Wong, W. H., Mocarski, E. S., Pera, R. A. R., Yakubov, E., & Cooke, J. P. (2012) · Cell · doi:10.1016/j.cell.2012.09.034 · Cited by 345
Fotin-Mleczek, M., Duchardt, K. M., Lorenz, C., Pfeiffer, R., Ojkić-Zrna, S., Probst, J., & Kallen, K.-J. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181f7dbe8 · Cited by 335 · cited 2×
“Although this naturally occurring protein is demonstrated to protect the mRNA from degradation, mRNA–protamine complexes were shown to induce the innate immune response strongly [73].”
(1995) · PubMed · Cited by 330
Recognition of viral nucleic acids in innate immunity
Yoneyama, M., & Fujita, T. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.633 · Cited by 313
Efficient generation of human iPSCs by a synthetic self-replicative RNA
Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312
RNA- and Virus-Independent Inhibition of Antiviral Signaling by RNA Helicase LGP2
Komuro, A., & Horvath, C. M. (2006) · Journal of Virology · doi:10.1128/jvi.01325-06 · Cited by 298
Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
Quintás‐Cardama, A., & Verstovšek, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0284 · Cited by 291
Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282
Reversal of Diabetes Insipidus in Brattleboro Rats: Intrahypothalamic Injection of Vasopressin mRNA
Jirikowski, G. F., Sanna, P. P., Maciejewski-Lenoir, D., & Bloom, F. E. (1992) · Science · doi:10.1126/science.1546298 · Cited by 282
Diebold, S. S., Massacrier, C., Akira, S., Paturel, C., Morel, Y., & Sousa, C. R. E. (2006) · European Journal of Immunology · doi:10.1002/eji.200636617 · Cited by 281
Gallie, D. R. (1998) · Gene · doi:10.1016/s0378-1119(98)00318-7 · Cited by 280
Wang, Y., Ludwig, J., Schuberth, C., Goldeck, M., Schlee, M., Li, H., Juranek, S., Sheng, G., Micura, R., Tuschl, T., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1863 · Cited by 258
Yakubov, E., Rechavi, G., Rozenblatt, S., & Givol, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.150 · Cited by 250
Zhu, F. X., King, S. M., Smith, E., Levy, D. E., & Yuan, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082420599 · Cited by 241
Negative regulation of the interferon response by an interferon-induced long non-coding RNA
Kambara, H., Niazi, F., Kostadinova, L., Moonka, D., Siegel, C., Post, A. B., Carnero, E., Barriocanal, M., Fortes, P., Anthony, D. D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku713 · Cited by 237
mRNA as gene therapeutic: How to control protein expression
Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232
Non-Viral Gene Delivery Methods
Wang, W., Li, W., Ma, N., & Steinhoff, G. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314010008 · Cited by 229
5’-triphosphate-dependent activation of PKR by RNAs with short stem-loops
Nallagatla, S. R., Hwang, J., Toroney, R., Zheng, X., Cameron, C. E., & Bevilacqua, P. C. (2007) · Science · doi:10.1126/science.1147347 · Cited by 222
Cationic lipids activate intracellular signaling pathways
Lonez, C., Vandenbranden, M., & Ruysschaert, J.-M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.009 · Cited by 221
Reprogramming human fibroblasts to pluripotency using modified mRNA
Mandal, P., & Rossi, D. J. (2013) · Nature Protocols · doi:10.1038/nprot.2013.019 · Cited by 219
Kettle, S., Khanna, A., Alcam√≠, A., Jassoy, C., Ehret, R., & Smith, G. L. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-3-677 · Cited by 207
Small molecule inhibitors of the RNA-dependent protein kinase
Jammi, N. V., Whitby, L. R., & Beal, P. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01318-4 · Cited by 205
In Vitro Transcription of Long RNA Containing Modified Nucleosides
Pardi, N., Muramatsu, H., Weissman, D., & Karikó, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_2 · Cited by 204
Chicken Cells Sense Influenza A Virus Infection through MDA5 and CARDIF Signaling Involving LGP2
Liniger, M., Summerfield, A., Zimmer, G., McCullough, K. C., & Ruggli, N. (2011) · Journal of Virology · doi:10.1128/jvi.00742-11 · Cited by 203
Current prospects for mRNA gene delivery
Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 200
Scheel, B., Teufel, R., Probst, J., Carralot, J., Geginat, J., Radsak, M. P., Jarrossay, D., Wagner, H., Jung, G., Rammensee, H., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425656 · Cited by 198
Diken, M., Kreiter, S., Selmi, A., Britten, C. M., Huber, C. G., Türeci, Ö., & Şahin, U. (2011) · Gene Therapy · doi:10.1038/gt.2011.17 · Cited by 192
Bonehill, A., Tuyaerts, S., Nuffel, A. M. T. V., Heirman, C., Bos, T. J., Fostier, K., Neyns, B., & Thielemans, K. (2008) · Molecular Therapy · doi:10.1038/mt.2008.77 · Cited by 185
Carroll, K. L., Elroy‐Stein, O., Moss, B., & Jagus, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31463-7 · Cited by 184
Xiang, Y., CONDIT, R. C., Vijaysri, S., Jacobs, B. L., Williams, B. R. G., & Silverman, R. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5251-5259.2002 · Cited by 177
Loiarro, M., Sette, C., Gallo, G., Ciacci, A., Fantò, N., Mastroianni, D., Carminati, P., & Ruggiero, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400613200 · Cited by 177
Recent trends in non‐viral vector‐mediated gene delivery
Pathak, A., Patnaik, S., & Gupta, K. C. (2009) · Biotechnology Journal · doi:10.1002/biot.200900161 · Cited by 170
Chauhan, D., Auclair, D., Robinson, E. K., Hideshima, T., Li, G., Podar, K., Gupta, D., Richardson, P. G. G., Schlossman, R. L., Krett, N. L., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205205 · Cited by 164
Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012) · Scientific Reports · doi:10.1038/srep00657 · Cited by 154
Lorenz, C., Fotin‐Mleczek, M., Roth, G. D., Becker, C., Dam, T. C., Verdurmen, W. P. R., Brock, R. E., Probst, J., & Schlake, T. (2011) · RNA Biology · doi:10.4161/rna.8.4.15394 · Cited by 152
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells
Grudzien‐Nogalska, E., Jemielity, J., Kowalska, J., Darżynkiewicz, E., & Rhoads, R. E. (2007) · RNA · doi:10.1261/rna.701307 · Cited by 152
Sen, G. C., & Sarkar, S. N. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_12 · Cited by 148
Li, Y., & Kiledjian, M. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.15 · Cited by 145
Nallagatla, S. R., & Bevilacqua, P. C. (2008) · RNA · doi:10.1261/rna.1007408 · Cited by 143
Pfaller, C. K., Li, Z., George, C. X., & Samuel, C. E. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.009 · Cited by 141
Challenges and advances towards the rational design of mRNA vaccines
Pollard, C., Koker, S. D., Saelens, X., Vanham, G. L., & Grooten, J. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.09.002 · Cited by 138
mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
Rejman, J., Tavernier, G., Bavarsad, N., Demeester, J., & Smedt, S. C. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.124 · Cited by 133
Involvement of the ubiquitin‐like domain of TBK1/IKK‐i kinases in regulation of IFN‐inducible genes
Ikeda, F., Hecker, C., Rozenknop, A., Nordmeier, R. D., Rogov, V. V., Hofmann, K., Akira, S., Dötsch, V., & Đikić, I. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601773 · Cited by 127
Vaccination with Messenger RNA (mRNA)
Pascolo, S. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-72167-3_11 · Cited by 126
Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 122
Tumor vaccination using messenger RNA: prospects of a future therapy
Kreiter, S., Diken, M., Selmi, A., Türeci, Ö., & Şahin, U. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.007 · Cited by 120
Dewitte, H., Lint, S. V., Heirman, C., Thielemans, K., Smedt, S. C. D., Breckpot, K., & Lentacker, I. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.011 · Cited by 118
Self-citationSingle-cell mRNA transfection studies: Delivery, kinetics and statistics by numbers
Leonhardt, C., Schwake, G., Stögbauer, T. R., Rappl, S., Kuhr, J.-T., Ligon, T. S., & Rädler, J. O. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.11.008 · Cited by 117
Koski, G. K., Karikó, K., Xu, S., Weissman, D., Cohen, P. A., & Czerniecki, B. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.3989 · Cited by 116
2-Aminopurine Inhibits the Double-Stranded RNA-Dependent Protein Kinase Both In Vitro and In Vivo
HU, Y., & Conway, T. W. (1993) · Journal of Interferon Research · doi:10.1089/jir.1993.13.323 · Cited by 115
Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism
Mays, L. E., Ammon-Treiber, S., Mothes, B., Alkhaled, M., Rottenberger, J., Müller-Hermelink, E. S., Grimm, M., Mezger, M., Beer-Hammer, S., von Stebut, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65351 · Cited by 113
Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles
Baba, M., Itaka, K., Kondo, K., Yamasoba, T., & Kataoka, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.017 · Cited by 109
Particle size and activation threshold: a new dimension of danger signaling
Rettig, L., Haen, S. P., Bittermann, A. G., von Boehmer, L., Fontecedro, A. C., Krämer, S. D., Knuth, A. K., & Pascolo, S. (2010) · Blood · doi:10.1182/blood-2009-11-247817 · Cited by 108
Harii, N., Lewis, C. J., Vasko, V., McCall, K. D., Benavides-Peralta, U., Sun, X., Ringel, M. D., Saji, M., Giuliani, C., Napolitano, G., et al. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0100 · Cited by 107
Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach
Plews, J. R., Li, J., Jones, M., Moore, H. D. M., Mason, C., Andrews, P. W., & Na, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014397 · Cited by 104
ADARs: Viruses and Innate Immunity
Samuel, C. E. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_148 · Cited by 103
The ReNAissanCe of mRNA-based cancer therapy
Van Lint, S., Renmans, D., Broos, K., Dewitte, H., Lentacker, I., Heirman, C., Breckpot, K., & Thielemans, K. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.957685 · Cited by 95
Self-citationInnate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins
Angel, M., & Yanik, M. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011756 · Cited by 91
Toshchakov, V. Y., Basu, S., Fenton, M. J., & Vogel, S. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.494 · Cited by 90
Jha, B. K., Polyakova, I. V., Kessler, P., Dong, B., Dickerman, B. K., Sen, G. C., & Silverman, R. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253443 · Cited by 87
Yang, S., Deng, P., Zhu, Z., Zhu, J., Wang, G., Zhang, L., Chen, A. F., Wang, T., Sarkar, S. N., Billiar, T. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401136 · Cited by 83
The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation
Ingrand, S., Barrier, L., Lafay-Chebassier, C., Fauconneau, B., Page, G., & Hugon, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.08.022 · Cited by 80
Myskiw, C., Arsenio, J., van Bruggen, R., Deschambault, Y., & Cao, J. (2009) · Journal of Virology · doi:10.1128/jvi.02570-08 · Cited by 77
ADAR1 is essential for intestinal homeostasis and stem cell maintenance
Qiu, W., Wang, X., Buchanan, M. E., He, K., Sharma, R. B., Zhang, L., Wang, Q., & Yu, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.125 · Cited by 74
Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy
Jha, B. K., Dong, B., Nguyen, C. T., Polyakova, I. V., & Silverman, R. H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.112 · Cited by 73
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
Dewitte, H., Verbeke, R., Breckpot, K., Smedt, S. C. D., & Lentacker, I. (2014) · Nano Today · doi:10.1016/j.nantod.2014.10.001 · Cited by 71
Self-citationAn RNA Editor, Adenosine Deaminase Acting on Double-Stranded RNA (ADAR1)
George, C. X., John, L., & Samuel, C. E. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0001 · Cited by 69
Schwartz, A. L., Malgor, R., Dickerson, E., Weeraratna, A. T., Slominski, A. T., Wortsman, J., Harii, N., Kohn, A. D., Moon, R. T., Schwartz, F., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0005 · Cited by 68
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways
Rajsbaum, R., & García‐Sastre, A. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.006 · Cited by 67
Anderson, D. M., Hall, L. L., Ayyalapu, A. R., Irion, V. R., Nantz, M. H., & Hecker, J. G. (2003) · Human Gene Therapy · doi:10.1089/10430340360535751 · Cited by 66
Schmolke, M., Patel, J. R., de Castro, E., Sánchez-Aparicio, M. T., Uccellini, M. B., Miller, J. C., Manicassamy, B., Satoh, T. K., Kawai, T., Akira, S., et al. (2014) · mBio · doi:10.1128/mbio.01006-14 · Cited by 63
Zhu, F. X., Sathish, N., & Yuan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010573 · Cited by 57
Andries, O., Filette, M. D., Smedt, S. C. D., Demeester, J., Poucke, M. V., Peelman, L. J., & Sanders, N. N. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.033 · Cited by 54
Bhattacharyya, S., Ratajczak, C. K., Vogt, S. K., Kelley, C., Colonna, M., Schreiber, R. D., & Muglia, L. J. (2010) · Blood · doi:10.1182/blood-2009-06-224782 · Cited by 53
Tavernier, G., Wolfrum, K., Demeester, J., Smedt, S. C. D., Adjaye, J., & Rejman, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.062 · Cited by 53
Drews, K., Tavernier, G., Demeester, J., Lehrach, H. R., Smedt, S. C. D., Rejman, J., & Adjaye, J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.025 · Cited by 46
He, X., Jia, H., Jing, Z., & Liu, D. X. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms122 · Cited by 42
The messenger's great message for vaccination
Pascolo, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1000871 · Cited by 40
Bax mRNA therapy using cationic liposomes for human malignant melanoma
Okumura, K., Nakase, M., Inui, M., Nakamura, S., Watanabe, Y., & Tagawa, T. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1214 · Cited by 31
Differential effect of thalidomide and dexamethasone on the transcription factor NF-κB
Rowland, T. L., McHugh, S. M., Deighton, J., Ewan, P. W., Dearman, R. J., & Kimber, I. (2001) · International Immunopharmacology · doi:10.1016/s0162-3109(00)00265-4 · Cited by 30
A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation
Nekhai, S. A., Bottaro, D. P., Woldehawariat, G., Spellerberg, A., & Petryshyn, R. (2000) · Peptides · doi:10.1016/s0196-9781(00)00297-7 · Cited by 24
BAY11 enhances OCT4 synthetic mRNA expression in adult human skin cells
Awe, J. P., Crespo, A. V., Li, Y., Kiledjian, M., & Byrne, J. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt163 · Cited by 18
Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization
Courreges, M. C., Kantake, N., Goetz, D. J., Schwartz, F., & McCall, K. D. (2012) · Molecules · doi:10.3390/molecules171012365 · Cited by 17
Mechanism of inhibition of lipopolysaccharide-induced interferon-β production by 2-aminopurine
Sugiyama, T., Gotou, T., Moriyama, K., Kajiura, N., Hasegawa, T., Tomida, J., Takahashi, K., Komatsu, T., Ueda, H., Sato, K., et al. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.06.008 · Cited by 15
Gupta, A., & Rath, P. C. (2014) · BioMed Research International · doi:10.1155/2014/817024 · Cited by 13
Pluripotent State Induction in Mouse Embryonic Fibroblast Using mRNAs of Reprogramming Factors
Elsayed, A. K., Zhang, Z., Zhang, L., Liu, Z., Abbott, L. C., Zhang, Y., & Li, B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151221840 · Cited by 12
Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Cited by
Sorted by citations
Advances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584
Nanomaterial Delivery Systems for mRNA Vaccines
Buschmann, M. D., Carrasco, M. J., Alishetty, S., Paige, M., Alameh, M. G., & Weissman, D. (2021) · Vaccines · doi:10.3390/vaccines9010065 · Cited by 582
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560
The landscape of mRNA nanomedicine
Huang, X., Kong, N., Zhang, X., Cao, Y., Langer, R., & Tao, W. (2022) · Nature Medicine · doi:10.1038/s41591-022-02061-1 · Cited by 511
Metadata
- Authors
- Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K.
- Affiliations
- Ghent University (BE)
- Corresponding author
- Remaut, Katrien
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 21
- Issue
- 1
- Pages
- 11-25
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1529085705
- Cited by
- 112
- References
- 150
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 10 · 2023: 9 · 2022: 16 · 2021: 18 · 2020: 16 · 2019: 14 · 2018: 5 · 2017: 5 · 2016: 4
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Funders
- European Molecular Biology Laboratory
- Fonds Wetenschappelijk Onderzoek
- Universiteit Gent
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- in vitro transcribed mRNA, innate immunity, immune evasion, non-viral gene therapy, mRNA expression
- MeSH terms
- Animals, Humans, Immunity, Innate, Immunotherapy, RNA, Messenger, Genetic Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review